IL153182A0 - Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv - Google Patents

Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv

Info

Publication number
IL153182A0
IL153182A0 IL15318201A IL15318201A IL153182A0 IL 153182 A0 IL153182 A0 IL 153182A0 IL 15318201 A IL15318201 A IL 15318201A IL 15318201 A IL15318201 A IL 15318201A IL 153182 A0 IL153182 A0 IL 153182A0
Authority
IL
Israel
Prior art keywords
dpp
inhibitors
heterocyclic compounds
enzyme dpp
compounds
Prior art date
Application number
IL15318201A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK2001/000467 external-priority patent/WO2002002560A2/en
Publication of IL153182A0 publication Critical patent/IL153182A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15318201A 2000-07-04 2001-07-04 Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv IL153182A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001040 2000-07-04
PCT/DK2001/000467 WO2002002560A2 (en) 2000-07-04 2001-07-04 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)

Publications (1)

Publication Number Publication Date
IL153182A0 true IL153182A0 (en) 2003-06-24

Family

ID=8159598

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15318201A IL153182A0 (en) 2000-07-04 2001-07-04 Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv

Country Status (13)

Country Link
EP (1) EP1561752A1 (no)
KR (1) KR20030014394A (no)
CN (1) CN1440288A (no)
AT (1) ATE299024T1 (no)
BR (1) BR0112123A (no)
CA (1) CA2411864A1 (no)
CZ (1) CZ200319A3 (no)
DE (1) DE60111849T2 (no)
ES (1) ES2244634T3 (no)
IL (1) IL153182A0 (no)
NO (1) NO20030021L (no)
RU (1) RU2003103103A (no)
ZA (1) ZA200209714B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004318013B8 (en) * 2004-03-15 2011-10-06 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7842707B2 (en) * 2004-07-23 2010-11-30 Nuada, Llc Peptidase inhibitors
CN102276627B (zh) * 2010-04-29 2013-07-31 山东轩竹医药科技有限公司 吡啶并杂环衍生物
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN103509023B (zh) * 2012-06-20 2014-08-27 成都苑东药业有限公司 黄嘌呤衍生物
CA2899646C (en) 2013-03-15 2021-08-31 Hydra Biosciences, Inc. Substituted xanthines and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205815A1 (de) * 1972-02-08 1973-08-16 Hoechst Ag Piperazinderivate und verfahren zu ihrer herstellung
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
ZA200209714B (en) 2003-08-19
RU2003103103A (ru) 2004-08-20
CN1440288A (zh) 2003-09-03
CZ200319A3 (cs) 2003-05-14
BR0112123A (pt) 2003-05-06
EP1561752A1 (en) 2005-08-10
NO20030021L (no) 2003-03-03
CA2411864A1 (en) 2002-01-10
DE60111849T2 (de) 2006-06-08
DE60111849D1 (de) 2005-08-11
ATE299024T1 (de) 2005-07-15
ES2244634T3 (es) 2005-12-16
KR20030014394A (ko) 2003-02-17
NO20030021D0 (no) 2003-01-03

Similar Documents

Publication Publication Date Title
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
WO2004033455A3 (en) Hemisuccinate salts of heterocyclic dpp-iv inhibitors
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
WO2003024965A3 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
NO2007010I2 (no) Sitagliptin, eventuelt i form av et farmasøytisk akseptabelt salt
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
EP1841426A4 (en) TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP1651623A4 (en) HEXAHYDRODIAZEPINONES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FOR THE TREATMENT OR PREVENTION OF DIABETES
ECSP055783A (es) Derivados de fenilalanina como inhibidores de dipeptidilpeptidasa para el tratamiento o prevención de diabetes
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
EP1784188A4 (en) DIPEPTIDYL-IV DIPEPTIDYL-IV INHIBITORY-CONTAINED TRIAZOLE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF DIABETES
DE60330485D1 (de) Zur behandlung von diabetes
GEP20125565B (en) Lactam compounds and their pharmaceutical use
WO2005044195A3 (en) Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
CY1108146T1 (el) ΑΝΑΣΤΟΛΕΙΣ ΤΗΣ β-ΑΜΙΝΟ-ΕΤΕΡΟΚΥΚΛΙΚΗΣ-ΔΙΠΕΠΤΙΔΥΛΙΚΗΣ ΠΕΠΤΙΔΑΣΗΣ ΓΙΑ ΤΗΝ ΑΓΩΓΗ Ή ΠΡΟΛΗΨΗ ΤΟΥ ΔΙΑΒΗΤΗ
GB0222495D0 (en) Compounds
EP1624874A4 (en) 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IN THE TREATMENT OR PREVENTION OF DIABETES
TW200517389A (en) Biaryloxymethylarenecarboxylic acids
ATE244717T1 (de) Inhibitoren des impdh-enzyms
WO2003082817A3 (en) Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2005065195A3 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
HK1075450A1 (en) heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
WO2006057945A3 (en) 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003260436A1 (en) Pyrimidine compounds